
FDA orders new warning on GLP-1s over rare eye condition linked to sudden blindness
By Berkeley Lovelace Jr.
The Food and Drug Administration said Monday that GLP-1 drugmakers must add a warning label about a rare eye condition that can cause sudden blindness.
This story was published by NBC News. Read the full article on their site.
Read the full story at nbcnews.com(opens in a new tab)







